Mukka Proteins’ Bengaluru order is worth Rs 474.89 crore
Key highlights
- Mukka Proteins reports a Rs 474.89 crore Bengaluru leachate-treatment order value excluding GST.
- The Bengaluru project has a four-year duration and an approximately six-month build timeline.
- Mukka Proteins holds a 76% stake in the project joint venture.
- The project requires approximately Rs 100 crore of CAPEX and serves Bengaluru Solid Waste Management Ltd.
powered by IRIS

Mukka Proteins Limited’s Bengaluru leachate-treatment project has an order value of Rs 474.89 crore excluding Goods and Services Tax (GST), a four-year duration and an approximately Rs 100 crore capital-expenditure requirement. The municipal project covers legacy leachate at two Bengaluru sites and will be undertaken through a joint venture in which Mukka Proteins holds 76%.
Know Mukka Proteins inside out
Results, valuation, peers and who's buying, in one view.
What is Mukka Proteins’ Bengaluru leachate-treatment contract?
Mukka Proteins’ contract covers legacy leachate treatment at Mittaganahalli and Kannur in Bengaluru for Bengaluru Solid Waste Management Ltd (BSWML). The presentation places the Rs 474.89 crore, excluding-GST order within its waste management and environmental solutions segment, rather than its fishmeal, alternate-protein or frozen-marine-products operations.
The company describes this segment as handling municipal wet-waste processing and large-scale leachate treatment for government bodies, with fees from municipalities as its stated earning mechanism. It also identifies carbon credits as a possible future upside for the platform, but it does not state a carbon-credit value, allocation or eligibility for the four-year Bengaluru project.
The project is described by Mukka Proteins as first-of-its-kind at this scale. That is the company’s characterization of the Rs 474.89 crore Bengaluru order; the presentation does not provide tender comparisons, leachate-treatment volumes, or a breakdown of contract value between the Mittaganahalli and Kannur sites.
How large is Mukka Proteins’ Bengaluru project?
The Bengaluru project’s disclosed order value is Rs 474.89 crore excluding GST, while its capital expenditure, or CAPEX, is approximately Rs 100 crore. The disclosed figures establish the scale of the order and the planned investment, but the presentation does not split CAPEX between equipment, civil works, technology or the two treatment locations.
Mukka Proteins gives an approximately six-month build timeline alongside a four-year project duration. The construction period is therefore much shorter than the stated operating term, although the slide does not specify a start date, commissioning date, payment milestones, annual billing amount or the timing of revenue recognition over the four years.
The Rs 474.89 crore figure is an order value, not a stated profit or cash-flow forecast. Although the presentation refers generally to long-term government contracts and cash-flow visibility in leachate management, it provides no project-level margin, operating-cost, financing-cost or working-capital estimate for the approximately Rs 100 crore investment.
How is Mukka Proteins participating in the Bengaluru project?
Mukka Proteins holds a 76% stake in the joint venture for the Bengaluru leachate-treatment project. The presentation links that majority stake with the approximately Rs 100 crore CAPEX requirement and the four-year contract, but it does not state how the capital requirement will be funded or whether funding will be contributed in proportion to the 76% stake.
The remaining 24% of the joint venture is implied by Mukka Proteins’ stated 76% holding, but the presentation does not identify the partner, joint-venture entity or the partner’s responsibilities. It also does not disclose which party will supply technology, execute construction, operate the treatment process or provide guarantees during the approximately six-month build phase.
This structure distinguishes the project from a wholly described operating facility because the presentation reports a stake rather than full project ownership. Investors can identify Mukka Proteins’ 76% participation, but cannot derive its exact share of the Rs 474.89 crore order value, CAPEX, costs or eventual earnings from the information supplied.
Got a follow-up? Ask IRIS
What role does the Bengaluru project play in Mukka Proteins’ business?
Mukka Proteins presents the four-year Bengaluru project as an environmental-services platform focused on municipal customers and government-body contracts. Management describes the strategic purpose as addressing groundwater and ecosystem pollution challenges while demonstrating its environmental technology and execution capability; these are stated business objectives, not project-performance results.
The company says the model could be replicated across Indian cities, but it provides no target number of cities, future order pipeline or timetable beyond the Bengaluru project’s approximately six-month build schedule. Its stated advantages for the segment are technology, regulation and execution barriers, together with long-term government contracts and operating leverage.
Bengaluru also appears in Mukka Proteins’ alternate-protein portfolio, where it lists 1,000 tonnes per day (TPD) of Black Soldier Fly processing capacity, compared with 200 TPD each at Mangaluru and Kochi. That capacity disclosure concerns organic-waste conversion into insect protein, oil, compost, humic acid and briquettes, whereas the Rs 474.89 crore contract concerns legacy leachate treatment; the presentation does not state that the two Bengaluru activities share assets or contract economics.
The company’s other disclosed verticals are measured differently: frozen and value-added marine products have combined freezing capacity of 167 TPD and cold storage of 1,926 TPD. In contrast, the Bengaluru environmental project is defined by a Rs 474.89 crore order, 76% joint-venture stake and four-year duration, showing that Mukka Proteins reports this municipal business through contract and investment metrics rather than production capacity.
Conclusion
Taken together, the disclosures show that Mukka Proteins is pursuing a sizeable municipal environmental-services assignment alongside its feed, alternate-protein and marine-product activities. The Rs 474.89 crore excluding-GST order, four-year duration and 76% joint-venture stake provide the core terms, while the stated treatment scope at Mittaganahalli and Kannur identifies the project’s operational setting.
The next disclosed execution point is the approximately six-month build period and the deployment of approximately Rs 100 crore of CAPEX. Matters to watch are progress toward that build schedule, the eventual funding and operating details of the joint venture, and any further disclosure on billing, margins, treatment volumes or the stated potential for replication in other cities.


